Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hyland’s Score Points Asking To Dismiss Class Action, But Loses Ruling

Executive Summary

Hyland’s fails to convince a federal court to dismiss nationwide class claims alleging false advertising of its baby products, but the judge says the two women alleging the firm made false claims about its homeopathic formulas have a “high hurdle” to demonstrate a nationwide class action.

You may also be interested in...

Hyland's Argues Class Action Trips On State Laws Despite 'Artful Pleading'

Hyland’s says a class action complaint alleging deceptive business practices and false advertising for its baby products is not suitable to represent a class of consumers outside New York. But the plaintiffs argue that the issue over class suitability should be considered during the certification stage.

Homeopathic Advertising Offers Slim Target For FTC Scrutiny – Industry

OTC homeopathic brands rely largely on word-of-mouth advertising from consumers’ friends and family members about their products’ safety and efficacy, stakeholders say at an FTC workshop. Consumers trust homeopathic OTCs even if they don’t understand products’ formulations, they say.

Colgate Says Hello To Subscription-Delivery Wtih Oral Care Line Acquisition

Colgate agrees to purchase Hello Products direct-to-consumer oral care brand, complementing  its Colgate brand and its Tom’s of Maine natural-positioned line. The firm will pay with a combination of cash and debt in the deal expected to close no later than the end of February.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts